Robert E. Humphreys
Directeur/Bestuurslid bij Balkore Industries, Inc.
Profiel
Robert E.
Humphreys is currently a Director at Balkore Industries, Inc. He was previously the Chief Operating Officer at NuGenerex Immuno-Oncology, Inc. from 1996 to 2015.
He also worked as a Professor at the University of Massachusetts Medical School.
Actieve functies van Robert E. Humphreys
Bedrijven | Functie | Begin |
---|---|---|
Balkore Industries, Inc.
Balkore Industries, Inc. Industrial MachineryProducer Manufacturing Balkore Industries, Inc. designs, manufactures, and sells cryogenic valves. The company manufactures industrial valves for specialized areas of industry, including a range of water, steam, fire service and other valves used extensively in clean water, fire prevention, mining and other industrial applications. It operates through its Australian subsidiary, Mack Valves Pty Ltd. The company was founded by Saul I. Reck in 1959 and is located in Worchester, MA. | Directeur/Bestuurslid | 14-04-2010 |
Eerdere bekende functies van Robert E. Humphreys
Bedrijven | Functie | Einde |
---|---|---|
UMass Chan Medical School | Corporate Officer/Principal | - |
NUGENEREX IMMUNO-ONCOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Balkore Industries, Inc.
Balkore Industries, Inc. Industrial MachineryProducer Manufacturing Balkore Industries, Inc. designs, manufactures, and sells cryogenic valves. The company manufactures industrial valves for specialized areas of industry, including a range of water, steam, fire service and other valves used extensively in clean water, fire prevention, mining and other industrial applications. It operates through its Australian subsidiary, Mack Valves Pty Ltd. The company was founded by Saul I. Reck in 1959 and is located in Worchester, MA. | Producer Manufacturing |
NuGenerex Immuno-Oncology, Inc.
NuGenerex Immuno-Oncology, Inc. BiotechnologyHealth Technology NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL. | Health Technology |